Answers are grounded in this paper and cite their sources.
Laboratory techniques preserve mRNA integrity at room temperature in a metal-free deep eutectic solvent, suggesting improved storage solutions for RNA-based therapeutics.
mRNA, a versatile vaccine and therapeutic platform of growing global importance, is notoriously unstable in aqueous environments due to various chemical degradation pathways, significantly limiting its potential. mRNA is particularly susceptible to hydrolytic degradation, often catalyzed by ubiquitous ribonucleases (RNases). Current stabilization methods rely heavily on cold-chain logistics, which are expensive and challenging to maintain, particularly in resource-limited settings. To address these challenges, ionic liquids and deep eutectic solvents have been explored as non-aqueous solvents for RNA extraction and preservation. However, most previously studied media contain toxic heavy metals or form ternary aqueous two-phase systems that do not protect against RNases. Moreover, model RNAs used in prior studies are simple and not representative of mRNAs. Here, we report the use of a simple, metal-free, hydrophobic deep eutectic solvent (hDES) composed of methyltrioctylammonium chloride and 1-decanol to extract and preserve mRNA at room temperature. Under optimized conditions, we achieve near 100% extraction efficiency into the protective hDES phase that effectively preserves mRNA integrity as assessed by capillary gel electrophoresis and an in vitro assay. We also demonstrate that this hDES system can extract complex mRNA strands of clinically relevant lengths and modifications. Importantly, the hDES phase also shields mRNA from RNase A exposure and suppresses hydrolytic degradation, enabling long-term preservation of mRNAs at room temperature for at least 227 days. Due to its ability to partition, preserve, and release mRNA, hDES composed of fatty alcohols and quaternary ammonium salts could be tailored for use as shelf-stable, non-aqueous precursors to RNA-based therapeutics such as cationic emulsions and lipid nanoparticles. This work potentially informs new strategies for the development of stable mRNA formulations, essential for next-generation vaccines and therapeutics.
No takes yet. Share an insight, caveat, or question.
Dinh et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: